Antoine G. Sreih

A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis

Carol A. Langford, David Cuthbertson, Steven R. Ytterberg et al. · Arthritis & Rheumatology · 2017 · 392 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility

F. David Carmona, Sarah Mackie, Jose‐Ezequiel Martín et al. · The American Journal of Human Genetics · 2015 · 178 citations · Full text

Life Sciences, Genetics, Immunology +17

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

Peter A. Merkel, Gang Xie, Paul A. Monach et al. · Arthritis & Rheumatology · 2016 · 178 citations · Full text

Life Sciences, Genetics, Immunology +17

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

Rona Smith, Rachel Jones, Ulrich Specks et al. · Annals of the Rheumatic Diseases · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Takayasu Arteritis

Carol A. Langford, David Cuthbertson, Steven R. Ytterberg et al. · Arthritis & Rheumatology · 2017 · 165 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13